Fingerprint
Dive into the research topics of 'First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically